Citations 1

PRX004 in variant amyloid transthyretin (ATTRv) amyloidosis: results of a phase 1, open-label, dose-escalation study

Amyloid | October 30, 2024 | Volume: 32 | Issue: 1 | Pages: 14-21

10.1080/13506129.2024.2420809 | PMID 39472768